Thrivent Financial for Lutherans’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $434K | Buy |
13,835
+69
| +0.5% | +$2.91K | ﹤0.01% | 2370 |
|
|
2026
Q1 | $761K | Sell |
13,766
-284
| -2% | -$13.5K | ﹤0.01% | 2035 |
|
|
2025
Q4 | $525K | Sell |
14,050
-644
| -4% | -$26.2K | ﹤0.01% | 2234 |
|
|
2025
Q3 | $595K | Sell |
14,694
-283
| -2% | -$9.35K | ﹤0.01% | 2017 |
|
|
2025
Q2 | $383K | Buy |
14,977
+38
| +0.3% | +$829 | ﹤0.01% | 2240 |
|
|
2025
Q1 | $319K | Sell |
14,939
-4,076
| -21% | -$91.1K | ﹤0.01% | 2209 |
|
|
2024
Q4 | $399K | Sell |
19,015
-1,776
| -9% | -$41.1K | ﹤0.01% | 2334 |
|
|
2024
Q3 | $468K | Buy |
20,791
+3,907
| +23% | +$75.4K | ﹤0.01% | 2268 |
|
|
2024
Q2 | $283K | Sell |
16,884
-760
| -4% | -$12.2K | ﹤0.01% | 2419 |
|
|
2024
Q1 | $228K | Sell |
17,644
-479
| -3% | -$5.74K | ﹤0.01% | 2440 |
|
|
2023
Q4 | $210K | Sell |
18,123
-482
| -3% | -$5.44K | ﹤0.01% | 2421 |
|
|
2023
Q3 | $238K | Sell |
18,605
-851
| -4% | -$12.1K | ﹤0.01% | 2357 |
|
|
2023
Q2 | $267K | Sell |
19,456
-699
| -3% | -$10K | ﹤0.01% | 2350 |
|
|
2023
Q1 | $309K | Sell |
20,155
-707
| -3% | -$10.8K | ﹤0.01% | 2282 |
|
|
2022
Q4 | $280K | Sell |
20,862
-162
| -0.8% | -$2.17K | ﹤0.01% | 2276 |
|
|
2022
Q3 | $279K | Buy |
21,024
+1,043
| +5% | +$18K | ﹤0.01% | 2250 |
|
|
2022
Q2 | $382K | Buy |
19,981
+3,424
| +21% | +$64.8K | ﹤0.01% | 2192 |
|
|
2022
Q1 | $330K | Buy |
16,557
+6
| +0% | +$121 | ﹤0.01% | 2326 |
|
|
2021
Q4 | $338K | Buy |
16,551
+112
| +0.7% | +$2.39K | ﹤0.01% | 2297 |
|
|
2021
Q3 | $354K | Sell |
16,439
-187
| -1% | -$4.5K | ﹤0.01% | 2278 |
|
|
2021
Q2 | $480K | Sell |
16,626
-40
| -0.2% | -$1.08K | ﹤0.01% | 2195 |
|
|
2021
Q1 | $407K | Sell |
16,666
-157
| -0.9% | -$3.55K | ﹤0.01% | 2299 |
|
|
2020
Q4 | $327K | Hold |
16,823
| – | – | ﹤0.01% | 2270 |
|
|
2020
Q3 | $293K | Sell |
16,823
-158
| -0.9% | -$3.37K | ﹤0.01% | 2190 |
|
|
2020
Q2 | $446K | Sell |
16,981
-22
| -0.1% | -$546 | ﹤0.01% | 1961 |
|
|
2020
Q1 | $411K | Sell |
17,003
-3,318
| -16% | -$81.1K | ﹤0.01% | 1823 |
|
|
2019
Q4 | $505K | Sell |
20,321
-137
| -0.7% | -$3.18K | ﹤0.01% | 1888 |
|
|
2019
Q3 | $436K | Buy |
20,458
+359
| +2% | +$9.83K | ﹤0.01% | 1908 |
|
|
2019
Q2 | $639K | Buy |
20,099
+4,671
| +30% | +$146K | ﹤0.01% | 1677 |
|
|
2019
Q1 | $509K | Buy |
15,428
+1,255
| +9% | +$39.1K | ﹤0.01% | 1798 |
|
|
2018
Q4 | $456K | Buy |
14,173
+311
| +2% | +$11.7K | ﹤0.01% | 1626 |
|
|
2018
Q3 | $595K | Buy |
13,862
+273
| +2% | +$12.9K | ﹤0.01% | 1595 |
|
|
2018
Q2 | $626K | Buy |
13,589
+998
| +8% | +$44.2K | ﹤0.01% | 1552 |
|
|
2018
Q1 | $500K | Buy |
12,591
+645
| +5% | +$23.9K | ﹤0.01% | 1645 |
|
|
2017
Q4 | $400K | Buy |
11,946
+236
| +2% | +$8.38K | ﹤0.01% | 1783 |
|
|
2017
Q3 | $434K | Buy |
11,710
+400
| +4% | +$15K | ﹤0.01% | 1644 |
|
|
2017
Q2 | $419K | Buy |
11,310
+840
| +8% | +$27.4K | ﹤0.01% | 1603 |
|
|
2017
Q1 | $294K | Buy |
10,470
+570
| +6% | +$16.1K | ﹤0.01% | 1753 |
|
|
2016
Q4 | $290K | Buy |
9,900
+410
| +4% | +$11.2K | ﹤0.01% | 1730 |
|
|
2016
Q3 | $258K | Buy |
+9,490
| New | +$215K | ﹤0.01% | 1760 |
|
|
2016
Q2 | – | Sell |
-8,430
| Closed | -$228K | – | 2040 |
|
|
2016
Q1 | $228K | Buy |
8,430
+590
| +8% | +$16.9K | ﹤0.01% | 1718 |
|
|
2015
Q4 | $236K | Buy |
+7,840
| New | +$252K | ﹤0.01% | 1689 |
|
Other funds holding PAHC
Thrivent Financial for Lutherans's PAHC Position: Q2 2026 in Review
Thrivent Financial for Lutherans increased its Phibro Animal Health (PAHC) stake by 0.5% in Q2 2026, buying an estimated $2.91K and bringing the position to 13,835 shares worth $434K. The position accounts for ﹤0.01% of the portfolio, ranked #2370.
Thrivent Financial for Lutherans first reported a position in PAHC in Q4 2015 and has held it in 42 quarters since. The position peaked at $761K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.
- Thrivent Financial for Lutherans held 13,835 shares of Phibro Animal Health worth $434K as of Q2 2026.
- Thrivent Financial for Lutherans bought 69 Phibro Animal Health shares in Q2 2026, an estimated $2.91K.
- Phibro Animal Health made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #2370 holding.
- Thrivent Financial for Lutherans first reported a position in Phibro Animal Health in Q4 2015 and has held it in 42 quarters since.
- Thrivent Financial for Lutherans's Phibro Animal Health position peaked at $761K in Q1 2026.
- 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.